Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users

Project Title Evaluation of the US Food and Drug Administration Sentinel Analysis Tools Using a Comparator with a Different Indication: Comparing the Rates of Gastrointestinal Bleeding in Warfarin and Statin Users
Date
Saturday, January 19, 2019
Location
Description

The authors of this manuscript tested the ability of Sentinel’s reusable analytic tools to identify the known association between warfarin and gastrointestinal bleeding (GIB). Statins, expected to have no effect on GIB, were the comparator. The authors further explored the impact of analytic features, including matching ratio and stratifying Cox regression analyses, on matched pairs. This study identified the expected GIB risk with warfarin compared with statins using an analytic tool developed for Sentinel. Findings suggest that comparators with different indications may be useful in surveillance in select circumstances. Finally, in the presence of differential censoring, stratification by matched pair may reduce the potential for bias in Cox regression analyses.

Corresponding Author

Ryan M. Carnahan, Department of Epidemiology, College of Public Health, University of Iowa, Iowa City, USA. Email: Ryan-Carnahan@uiowa.edu

Authors

Ryan M. Carnahan, Joshua J. Gagne, Christian Hampp, Charles E. Leonard, Sengwee Toh, Candace C. Fuller, Sean Hennessy, Laura Hou, Noelle M. Cocoros, Genna Panucci, Tiffany Woodworth, Austin Cosgrove, Aarthi Iyer, Elizabeth A. Chrischilles

Related Assessments